The acquired business with annual sales of approximately € 10 mln will be integrated into IMCD China’s business unit Pharma and will be synergistic with IMCD’s existing product range.
This website uses cookies to improve your user experience
We use cookies for a variety of purposes, such as website functionality and helping target our marketing activities. Click "accept" to accept our cookies. You can change the cookie settings by clicking "change settings".